Do You Think UFP Technologies (UFPT) is an Attractive Investment? – Yahoo Finance
Headwaters Capital Management, an investment management company, released its third-quarter 2022 investor letter. A copy of the same can be downloaded here. In the third quarter, the fund’s portfolio gained 1.6% net compared to a -3.4% decline for the Russell Mid Cap index. The portfolio’s outperformance in the third quarter was attributed to stock selection. In addition, you can check the top 5 holdings of the fund to know its best picks in 2022.
Headwaters Capital discussed stocks like UFP Technologies, Inc. (NASDAQ:UFPT) in the Q3 2022 investor letter. Headquartered in Newburyport, Massachusetts, UFP Technologies, Inc. (NASDAQ:UFPT) is a manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical industry. On October 25, 2022, UFP Technologies, Inc. (NASDAQ:UFPT) stock closed at $89.00 per share. One-month return of UFP Technologies, Inc. (NASDAQ:UFPT) was 4.56% and its shares gained 47.06% of their value over the last 52 weeks. UFP Technologies, Inc. (NASDAQ:UFPT) has a market capitalization of $673.421 million.
Headwaters Capital made the following comment about UFP Technologies, Inc. (NASDAQ:UFPT) in its Q3 2022 investor letter:
“UFP Technologies, Inc. (NASDAQ:UFPT) engages in the design, development and manufacturing of custom-engineered components, devices and packaging primarily in the medical end market. Leveraging its access to and engineering expertise in specialty foams, plastics and composites, the company designs and manufactures parts and devices that are singleuse in nature. Representative products include surgical robotic drapes, vascular tools, wound therapy products and orthopedic devices.
In many ways, UFP serves as an outsourced R&D partner for clients by assisting during front-end product design and engineering. Through the development of customized machinery, manufacturing expertise and a network of FDA certified manufacturing facilties and clean rooms, UFP can oversee the transition from prototype to commercial production. The highly engineered nature of UFP’s products and the rigorous FDA approval process for both new product introductions and manufacturing techniques leads to deep and long-lasting customer relationships for the company. UFP counts 26 of the top 30 medical device companies as customers, which highlights the company’s design, engineering and manufacturing expertise in the medical market.
UFP’s revenues are highly visible as the medical end market has relatively stable demand given the critical nature of the products and most of UFP’s end products are consumable in nature in the form of single-use or single patient devices. Long-term contracts with high switching costs provide even greater revenue visibility for the company. The steady nature of UFP’s revenue allows the company to invest confidently in both R&D and capacity expansions that generate high returns on capital. As the company continues to focus more on product development alongside customers, it not only builds stronger customer relationships, but it will also result in higher margin revenue as these more innovative products come to market…” (Click here to read the full text)
Photo by National Cancer Institute on Unsplash
UFP Technologies, Inc. (NASDAQ:UFPT) is not on our list of 30 Most Popular Stocks Among Hedge Funds. As per our database, 5 hedge fund portfolios held UFP Technologies, Inc. (NASDAQ:UFPT) at the end of the second quarter which was 8 in the previous quarter.
We discussed UFP Technologies, Inc. (NASDAQ:UFPT) in another article and shared the stock pick of Touk Sinantha’s AltraVue Capital. In addition, please check out our hedge fund investor letters Q3 2022 page for more investor letters from hedge funds and other leading investors.
Suggested Articles:
Top 10 Women Owned Stocks To Buy
10 Most Undervalued Stocks To Buy
11 Best Low Risk Stocks To Invest In
Disclosure: None. This article is originally published at Insider Monkey.
Related Quotes
With that, I'd like to pass the call over to Moshe Mizrahy, chairman and CEO. Moshe, please go ahead. With me today are Dr. Michael Kreindel, our co-founder and chief technology officer; Yair Malca our CFO; Shakil Lakhani, our president in North America; Dr. Spero Theodorou, our chief medical officer; and Rafael Lickerman, our VP of finance.
Yahoo Finance tech reporter Allie Garfinkle joins the Live show to break down Amazon's third-quarter earnings report.
QuantumScape continues to make step-by-step progress toward commercialization of its EV battery technology.
Chief Executive Parag Agrawal, Chief Financial Officer Ned Segal and Vijaya Gadde, Twitter's head of legal policy, received a "golden parachute" clause in Twitter's merger with Musk's X Holdings.
It is hard to get excited after looking at EQT's (NYSE:EQT) recent performance, when its stock has declined 11% over…
The successful entrepreneur and one of the hit show's most popular investors ends a long suspense.
Friday is your last chance to buy at the 9.62% rate. But there are other important issues to consider.
Carlisle (CSL) delivered earnings and revenue surprises of 5.01% and 1.28%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Gilead (GILD) delivered earnings and revenue surprises of 31.94% and 15.06%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Shares of Twitter are moving higher in the final hour of trading ahead of the company going private following Elon Musk's acquisition.
U.S. Steel (X) delivered earnings and revenue surprises of 1.56% and 5.88%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
For many investors, 2021 was ideal. The benchmark S&P 500 endured no more than a 5% correction for the entirety of the year, and the major stock indexes finished higher by a double-digit percentage. All three major U.S. stock indexes have plunged into a bear market, with volatility hitting levels not seen since 2009.
Verizon (VZ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Pioneer Natural Resources (PXD) delivered earnings and revenue surprises of 0.67% and 7.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
AGNC Investment (NASDAQ: AGNC) bounced around quite a bit on Thursday, surging early in the trading day, up as much as 5.6%, before falling later to end the day down 0.4%. The major stock market indexes were mixed on Thursday as the Dow Jones Industrial Average was up 199 points (0.6%) while the S&P 500 was down 23 points (-0.6%) and the Nasdaq was off 178 points (-1.6%). AGNC Investment surged early on some good macroeconomic news and industry news.
Microsoft's (NASDAQ: MSFT) stock price dropped 8% on Wednesday, Oct. 26, after the tech giant posted its latest quarterly numbers. In the first quarter of fiscal 2023, which ended on Sept. 30, Microsoft's revenue rose 11% year over year (and grew 16% in constant currency terms) to $50.
Southwestern Energy (SWN) delivered earnings and revenue surprises of 6.67% and 127.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Shopify's bottom line is deep in the red, though some nuance is needed when discussing the numbers.
In this article, we discuss the 11 best very cheap stocks to buy according to hedge funds. If you want to see more stocks in this selection, check out 5 Best Very Cheap Stocks To Buy Now According To Hedge Funds. On June 13, CNBC reported that the S&P 500 ended more than 21% below […]
Crocs (CROX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.